“…4.9.22. 1-(2-Methyl-1-oxo-1,2-dihydroisoquinolin-5-yl)-3-((2-(4methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)methyl)urea(19). From 18, procedures G and F, yield 81% (in 2 steps), white solid, mp = 245.9−247.6 °C;1 H NMR (300 MHz, DMSO-d 6 ): δ 8.58 (s, 1H), 8.09 (d, J = 7.9 Hz, 1H), 7.68 (d, J = 7.9 Hz, 2H), 7.45 (m, 3H), 7.05 (m, 1H), 6.70 (d, J = 7.7 Hz, 1H), 4.36 (d, J = 5.7 Hz, 2H), 3.50 (s, 3H), 2.78 (m, 2H), 1.72 (m, 2H), 1.29 (m, 2H), 0.95 (d, J = 6.4 Hz, 3H); 13 C NMR (100 MHz, DMSO-d 6 ): δ 161.1, 160.6, 155.5, 137.4, 134.4, 133.1, 130.9, 128.6, 126.3, 126.0, 123.3, 120.9, 113.8, 99.1, 50.0, 36.3, 33.8, 30.2, 21.8; HRMS (FAB): calcd for C 23 H 27 F 3 N 5 O 2 [M + H] + , 474.2039; found, 474.2115.4.9.23.…”